Ironwood Pharmaceuticals, Inc. (IRWD) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 5.12M | 74.58M | 47.58M | -15.07M | 19.95M | 15.21M | 9.88M | 33.47M | 44.98M | 35.83M | 32.46M | 34.96M | 80.17M | 79.18M | 69.09M | 61.37M | 64.12M | 64.57M | 75.06M | 48.57M |
| Operating CF Margin % | 4.81% | 156.31% | 38.98% | -17.68% | 48.5% | 16.8% | 10.79% | 35.45% | 60.08% | 30.48% | 28.54% | 32.56% | 77.04% | 73.86% | 63.6% | 63.11% | 65.75% | 55.13% | 72.35% | 46.69% |
| Operating CF Growth % | -74.34% | 390.17% | 381.37% | -145.03% | -55.64% | -57.54% | -69.55% | -4.28% | -43.89% | -54.74% | -53.02% | -43.02% | 25.02% | 22.63% | -7.96% | 26.35% | -12.99% | 25.34% | 39.96% | 141.78% |
| Net Income | 40.77M | 61.4M | 40.08M | 23.6M | -37.39M | 3.19M | 3.65M | -860K | -4.16M | -1.09M | 13.95M | -1.06B | 45.71M | 48.87M | 50.32M | 37.08M | 38.8M | 41.37M | 55.84M | 391.3M |
| Depreciation & Amortization | 443K | 1.4M | 475K | 467K | 479K | 485K | 507K | 506K | 513K | 512K | 507K | 270K | 286K | 340K | 363K | 360K | 355K | 358K | 358K | 396K |
| Stock-Based Compensation | 0 | 11.96M | 3.61M | 4.52M | 5.29M | 0 | 8.33M | 8.57M | 8.38M | 8.7M | 7.91M | 35.81M | 7.13M | 7.29M | 7.07M | 6.6M | 6.09M | 0 | 6.21M | 4.59M |
| Deferred Taxes | 19.2M | 40.13M | 27.77M | 14.11M | 670K | 41.1M | 7.68M | 13.26M | 6.05M | 31.32M | 14.26M | 0 | 17.05M | 20.13M | 16.02M | 14.89M | 14.71M | 1.93M | 2.57M | -337.8M |
| Other Non-Cash Items | 4.52M | -113.78M | 851K | 919K | 825K | 4.05M | 355K | 587K | 622K | 4.93M | 586K | 1.06B | 383K | 420K | 249K | 1.2M | -193K | 14.8M | 3.95M | 9.09M |
| Working Capital Changes | -59.81M | 73.46M | -25.21M | -58.68M | 50.08M | -33.61M | -10.63M | 11.41M | 33.58M | -8.54M | -4.75M | -2.66M | 9.61M | 2.13M | -4.92M | 1.24M | 4.36M | 6.1M | 6.13M | -19.01M |
| Change in Receivables | -59.1M | 73.62M | -34.19M | -46.4M | 42.12M | -5.68M | -18.09M | 13.91M | 57.11M | -4.58M | -5.56M | -3.24M | 14.3M | 937K | -14.34M | 3.01M | 18.38M | -12.41M | 333K | -15.24M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -4.89M | -318K | 10.69M | -13.84M | 9.66M | -5.75M | 69K | -2M | -12.53M | -12.55M | 6.59M | 0 | 705K | -2.01M | 4.66M | -3.65M | -7.12M | 4.07M | 3.72M | -2.49M |
| Cash from Investing | 0 | 1K | -2K | -2K | -31K | 0 | -16K | -58K | -68K | -4.19M | -22.63M | -999.49M | -13K | 27K | -66K | -88K | -9K | -128K | -137K | 0 |
| Capital Expenditures | 0 | -3K | -2K | -2K | -31K | 0 | -16K | -58K | -68K | -211K | -49K | 0 | -13K | 27K | -66K | -88K | -9K | -128K | -137K | 0 |
| CapEx % of Revenue | - | 0.01% | 0% | 0% | 0.08% | - | 0.02% | 0.06% | 0.09% | 0.18% | 0.04% | - | 0.01% | 0.03% | 0.06% | 0.09% | 0.01% | 0.11% | 0.13% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.98M | -22.58M | -999.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 122K | 0 | 88K | 6K | -14.89M | -27.16M | -49.37M | -15.55M | -50.9M | -74.99M | 399.07M | 3.98M | 2.81M | 797K | -150.28M | -90.87M | -18.59M | 6.16M | 5.66M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | -12.84M | -25M | -50M | -25M | -25M | -75M | 0 | 0 | 0 | 0 | -120.7M | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 122K | 0 | 88K | 6K | 203K | 0 | 749K | 10.06M | 998K | 12K | 0 | 3.98M | 2.81M | 0 | -29.58M | -92.5M | -18.59M | 6.16M | 5.66M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -33.9M | -92.5M | -24.13M | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | -2.25M | -2.16M | -121K | -616K | -26.9M | 0 | 399.07M | 0 | 0 | 797K | 0 | 1.62M | 0 | 0 | 0 |
| Net Change in Cash | 5.01M | 75.05M | 47.55M | -15.63M | 19.92M | 348K | -17.31M | -16.02M | 29.39M | -19.31M | -65.16M | -565.46M | 84.14M | 82.02M | 69.82M | -89.01M | -26.76M | 45.85M | 81.09M | 54.23M |
| Free Cash Flow | 5.12M | 74.58M | 47.58M | -15.07M | 19.92M | 15.21M | 9.87M | 33.41M | 44.92M | 35.62M | 32.41M | 34.96M | 80.16M | 79.21M | 69.03M | 61.28M | 64.11M | 64.44M | 74.93M | 48.57M |
| FCF Margin % | 4.81% | 156.31% | 38.98% | -17.68% | 48.42% | 16.8% | 10.78% | 35.39% | 59.99% | 30.3% | 28.5% | 32.56% | 77.03% | 73.89% | 63.54% | 63.02% | 65.74% | 55.02% | 72.22% | 46.69% |
| FCF Growth % | -74.3% | 390.18% | 382.13% | -145.11% | -55.64% | -57.29% | -69.55% | -4.45% | -43.96% | -55.03% | -53.05% | -42.94% | 25.02% | 22.92% | -7.88% | 26.17% | -13% | 25.16% | 39.71% | 146.39% |
| FCF per Share | 0.03 | 0.42 | 0.27 | -0.09 | 0.12 | 0.09 | 0.06 | 0.21 | 0.28 | 0.23 | 0.17 | 0.23 | 0.43 | 0.43 | 0.37 | 0.33 | 0.34 | 0.39 | 0.45 | 0.30 |
| FCF Conversion (FCF/Net Income) | 0.13x | -32.77x | 1.19x | -0.64x | -0.53x | 6.74x | 2.71x | -38.91x | -10.81x | -32.97x | 2.12x | -0.03x | 1.75x | 1.62x | 1.37x | 1.65x | 1.65x | 1.56x | 1.34x | 0.12x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |